• Integration of antibody-based and genomic methods improves detection of production issues.
• Advanced analytics reduce process variability and enhance product consistency.
• The proposed framework supports robust quality control in biopharmaceutical manufacturing.
• Findings offer actionable insights for industry practitioners and researchers.
Download Full PDF: Antibody-Based and Genomic Approaches for the Detection and Evaluation of Common Issues in Biopharmaceutical Production | SinoBioData | SinoBioData